Table 2.
Parameter (unit) | Group I, control | Group II, calculi induced | Group III, cystone treated |
Curative regimen |
Preventive regimen |
||||
---|---|---|---|---|---|---|---|---|---|
Group IV, PtE | Group V, ChE | Group VI, AlE | Group VII, PtE | Group VIII, ChE | Group IX, AlE | ||||
Urine (mg/dL) | |||||||||
Oxalate | 0.28 ± 0.01 | 2.61 ± 0.17*a | 0.46 ± 0.10* | 2.28 ± 0.30 | 2.40 ± 0.20 | 1.30 ± 0.18* | 2.20 ± 0.20 | 2.18 ± 0.40 | 0.84 ± 0.02* |
Calcium | 1.18 ± 0.03 | 3.85 ± 0.18*a | 1.34 ± 0.10* | 3.52 ± 0.36 | 3.38 ± 0.32 | 2.18 ± 0.19* | 3.22 ± 0.30 | 3.20 ± 0.22 | 2.10 ± 0.14* |
Phosphate | 2.96 ± 0.04 | 6.82 ± 0.13*a | 3.36 ± 0.03* | 6.50 ± 0.28 | 6.56 ± 0.47 | 4.62 ± 0.12* | 5.89 ± 0.29* | 6.20 ± 0.30 | 3.31 ± 0.16* |
Kidney (mg/g) | |||||||||
Oxalate | 1.36 ± 0.02 | 4.85 ± 0.11*a | 2.15 ± 0.03* | 4.12 ± 0.38 | 4.52 ± 0.18 | 3.18 ± 0.08* | 4.25 ± 0.24 | 4.38 ± 0.26 | 2.28 ± 0.01* |
Calcium | 3.02 ± 0.03 | 4.94 ± 0.21*a | 1.82 ± 0.27* | 4.26 ± 0.32 | 4.30 ± 0.22 | 3.22 ± 0.11†† | 4.42 ± 0.38 | 4.32 ± 0.44 | 2.50 ± 0.28* |
Phosphate | 2.58 ± 0.04 | 3.88 ± 0.11*a | 1.62 ± 0.03* | 3.66 ± 0.36 | 3.37 ± 0.14 | 3.00 ± 0.06* | 3.46 ± 0.21 | 3.35 ± 0.16 | 3.22 ± 0.08* |
Serum (mg/dL) | |||||||||
BUN | 38.21 ± 0.16 | 52.67 ± 0.46*a | 42.60 ± 0.38* | 52.50 ± 0.62 | 53.26 ± 0.28 | 48.25 ± 0.63* | 52.88 ± 0.32 | 54.20 ± 0.68 | 42.30 ± 0.12* |
Creatinine | 0.56 ± 0.03 | 0.98 ± 0.08*a | 0.58 ± 0.01† | 0.88 ± 0.20 | 0.84 ± 0.10 | 0.62 ± 0.03† | 0.68 ± 0.11 | 0.64 ± 0.03 | 0.61± 0.06† |
Uric acid | 1.26 ± 0.04 | 3.48 ± 0.11*a | 1.88 ± 0.03* | 3.18 ± 0.07 | 3.32 ± 0.27 | 2.38 ± 0.09* | 3.42 ± 0.28 | 3.28 ± 0.10 | 2.18 ± 0.01* |
Data were analysed by ANOVA followed by Dunnett’s test. All values are expressed as mean ± SEM (n = 6);
Comparisions are made with Group I;
P < 0.05.
P < 0.01.
P < 0.001.